Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed the potential of a respiratory syncytial virus vaccine in children, as well as ongoing efforts to get childhood vaccination rates back on track.
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed whether respiratory syncytial virus (RSV) vaccines could become part of the immunization schedule and how her practice is addressing immunization rates in children.
Transcript
When RSV vaccines for infants do become available in the United States, are you expecting them to be included on the childhood immunization schedule? What will families need to know?
So I think that really comes down to what that looks like, how effective it is. I think if there's broad public health implications, and of course, if we can keep an infant from getting seriously ill, then I can see it potentially definitely getting connected or getting added to the plethora of infant vaccines that we give. Honestly, I think we’ve got to wait and see what it looks like and the timing.
How is your practice working to try and get families back on track with childhood immunizations?
So, I think that you're absolutely right, we did fall behind on not just COVID-19 and flu vaccinations but other childhood vaccines. So, it's a process approach and it's an individual approach. From a process approach, our practice is reaching out to children who aren't fully immunized and trying to get them in and working with parents to be flexible on how to do that. We approach any child that comes in for a sick visit, even, and we always review immunizations during that time. You know, the harder decision or the harder challenges [are] for families who've chosen not to immunize their children across the board and that is ongoing conversations about trust and dispelling myths, and that is sometimes a very long haul. And that was prepandemic, but I do think that the pandemic has worsened some of that.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Conflicts of Interest in Federal Vaccine Advisory Committees at Historic Lows Despite RFK Jr Claims
August 19th 2025Research reveals a significant decline in reported conflicts of interest among the CDC's and FDA's vaccine advisory committees, challenging Robert F. Kennedy Jr's claims.
Read More